- Principal Investigator: Shilpa D. Kadam, PhD
- Institution: Axonis Therapeutics
- Grant Number: 2023.1
- Funding Amount: $55,000
- Percentage Dispersed: 100%
- Grant Status: Signed & Active
You can find our press release here.
You can find our press release here.